Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech will be a scientific contributor to the third ECI Microbial Engineering Conference (ME III), sharing its latest advances towards continuous production of biotechnological products.
Led by Mr. Florian Simon, the enGenes team at ME III will present the latest data from its participation in the ECOnti project that is developing an accelerated, low ecological footprint manufacturing platform for the continuous production of biotechnological products.
Novel E. coli strain
enGenes will present a poster “Engineering of a Novel E. coli Strain for Sustainable, End-to-End Continuous Manufacturing of Biomolecules”, authored by Florian Simon, MSc. that explores one aspect of the ECOnti work.
The poster will highlight application of proprietary enGenes technologies, such as -eXcess™ technology to optimize the manufacturing of high-quality plasmid DNA for gene therapy and vaccine development as well as the -eXchange™ platform for antibiotic-free and resistance marker-free manufacturing of recombinant proteins and plasmid DNA.
Comments